BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

American Hospital Resources, Inc. Issues Update


10/19/2005 5:10:38 PM

HONOLULU, March 31 /PRNewswire-FirstCall/ -- American Hospital Resources, Inc. (OTC Bulletin Board: AMHR; Berlin (WKN) 913541) recently announced that the board of directors has retained Judah Marvin Feigenbaum's services to spearhead the acquisition efforts of the Company. Mr. Feigenbaum's 30 years of experience in the healthcare industry, with a special focus on acquisitions and consolidations, make him the perfect agent to direct the activities of the Company toward achieving it's goals in the Institutional Pharmaceutical Marketplace. In order to get the most efficient use of his relationships and experience, Mark Buck will retain the position of CEO until such time as the initial rollup is complete. It has been determined that Mr. Feigenbaum can be more effective in structuring acquisitions without immediately accepting the responsibilities of CEO.

Mr. Feigenbaum said, "Given the number of potential acquisitions requiring due diligence, both the Board and I feel that the day to day responsibilities of CEO would be a distraction from my primary mission. My primary responsibility to AMHR is to pursue these opportunities."

Additionally, the Company is scheduling presentations to the European investment community. As a result of our listing on the Berlin Stock Exchange, AMHR has been invited to speak to more than a dozen brokerage and analyst groups in Munich, Frankfurt, Dusseldorf, Hamburg and Berlin. It is anticipated that these presentations will take place during the second quarter of this year.

American Hospital Resources, Inc. anticipates acquiring and consolidating groups of Institutional Pharmacies. AMHR plans to acquire and consolidate pharmacy operations in several regions of the country with a plan to gain labor efficiencies as well as increase its pharmaceutical buying power and enhance its pricing and purchasing terms with the pharmaceutical supply houses.

Except for historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risk and uncertainties, including but not limited to economic, competitive, governmental, political and technological factors affecting the Company's potential revenues, operations, markets, products and prices and other factors discussed in the Company's various filings with the Securities and Exchange Commission.

For more information please contact Investor Relations for American Hospital Resources, Inc., +1-888-918-8847, invrelations@amhrinc.com.

American Hospital Resources, Inc.

CONTACT: Investor Relations for American Hospital Resources, Inc.,+1-888-918-8847, invrelations@amhrinc.com



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES